T2 Biosystms Inc
T2 Biosystems, Inc., an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2… Read more
Market Cap & Net Worth: T2 Biosystms Inc (TTOO)
T2 Biosystms Inc (NASDAQ:TTOO) has a market capitalization of $2.55 Million ($2.55 Million) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #37493 globally and #12222 in its home market, demonstrating a -3.59% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying T2 Biosystms Inc's stock price $0.12 by its total outstanding shares 21043000 (21.04 Million).
T2 Biosystms Inc Market Cap History: 2015 to 2025
T2 Biosystms Inc's market capitalization history from 2015 to 2025. Data shows change from $1.15 Trillion to $2.55 Million (-74.82% CAGR).
T2 Biosystms Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how T2 Biosystms Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
18.36x
T2 Biosystms Inc's market cap is 18.36 times its annual revenue
0.68x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.15 Trillion | $2.81 Million | -$45.29 Million | 409190.22x | N/A |
| 2016 | $553.43 Billion | $4.08 Million | -$54.80 Million | 135644.83x | N/A |
| 2017 | $433.49 Billion | $4.67 Million | -$62.43 Million | 92903.09x | N/A |
| 2018 | $316.70 Billion | $10.50 Million | -$51.15 Million | 30161.63x | N/A |
| 2019 | $123.10 Billion | $8.34 Million | -$63.11 Million | 14769.23x | N/A |
| 2020 | $130.47 Billion | $18.13 Million | -$49.21 Million | 7196.17x | N/A |
| 2021 | $54.31 Billion | $28.06 Million | -$53.49 Million | 1935.70x | N/A |
| 2022 | $2.99 Billion | $22.30 Million | -$63.37 Million | 133.97x | N/A |
| 2023 | $132.04 Million | $7.19 Million | -$50.08 Million | 18.36x | N/A |
Competitor Companies of TTOO by Market Capitalization
Companies near T2 Biosystms Inc in the global market cap rankings as of March 18, 2026.
Key companies related to T2 Biosystms Inc by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #91 globally with a market cap of $176.18 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #154 globally with a market cap of $120.38 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.34 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #512 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #91 | Thermo Fisher Scientific Inc | NYSE:TMO | $176.18 Billion | $470.00 |
| #154 | Danaher Corporation | NYSE:DHR | $120.38 Billion | $191.39 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.34 Billion | $586.37 |
| #512 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
T2 Biosystms Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, T2 Biosystms Inc's market cap moved from $1.15 Trillion to $ 2.55 Million, with a yearly change of -74.82%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $2.55 Million | -71.19% |
| 2024 | $8.84 Million | -93.31% |
| 2023 | $132.04 Million | -95.58% |
| 2022 | $2.99 Billion | -94.50% |
| 2021 | $54.31 Billion | -58.37% |
| 2020 | $130.47 Billion | +5.98% |
| 2019 | $123.10 Billion | -61.13% |
| 2018 | $316.70 Billion | -26.94% |
| 2017 | $433.49 Billion | -21.67% |
| 2016 | $553.43 Billion | -51.92% |
| 2015 | $1.15 Trillion | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of T2 Biosystms Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.55 Million USD |
| MoneyControl | $2.55 Million USD |
| MarketWatch | $2.55 Million USD |
| marketcap.company | $2.55 Million USD |
| Reuters | $2.55 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.